Clinical Trial Update: A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial update assesses the safety and efficacy of concurrent chemoradiation with paclitaxel as adjuvant therapy for post-operative, advanced endomet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Korean Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN